Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Dental Devices
Return to: MDBR Home | Specialty Devices | Dental Devices

Antibe Therapeutics launches Neomem FlexPlus for oral surgery

Published 17 August 2016

Citagenix, a subsidiary of Antibe Therapeutics, has launched Neomem FlexPlus, a high-performance barrier membrane for regenerative procedures in oral surgery.

Data suggest that Neomem FlexPlus exceeds performance of a leading barrier membrane in areas that are considered highly important to dental clinicians.

Neomem FlexPlus is a single layer collagen membrane derived from porcine peritoneum. Suture pull-out testing has shown this membrane to be biomechanically strong yet conformability evaluations demonstrate the ability to adapt to the contour of the surgical site. Neomem FlexPlus can be placed wet or dry in situ and it hydrates quickly, providing handling characteristics that make surgical placement easy.

Test data and clinical experience suggest that Neomem FlexPlus outperforms a leading barrier membrane in four metrics, specifically strength, handling, resorption and tissue response.

Antibe CEO Dan Legault said: “The launch of Neomem FlexPlus provides Citagenix with its strongest barrier membrane yet, and a direct competitor to the leading product in the market.

“We see an exciting future for Citagenix and look forward to accelerating growth through new product initiatives and our footprint expansion strategy.”

Source: Company Press Release